Evidence map›Paper›PMID 26348392›Full record

ArticleComparative biochemistry and physiology. Toxicology & pharmacology : CBP2015

Transcriptional control analyses of the Xiphophorus melanoma oncogene.

Janine Regneri, Jean-Nicolas Volff, Manfred Schartl

Open access · greenAbstract read
In one paragraph

Article in Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Janine RegneriPhysiological Chemistry, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany.
Jean-Nicolas VolffInstitut de Génomique Fonctionelle de Lyon, Ecole Normale Supérieure de Lyon, 46, allée d'Italie, 69364 Lyon cedex 07, France.
Manfred SchartlPhysiological Chemistry, Biocenter, University of Würzburg, Am Hubland, Würzburg, Germany; Comprehensive Cancer Center Mainfranken, University Clinic Würzburg, Würzburg, Germany. Electronic address: phch1@biozentrum.uni-wuerzburg.de.
University of Würzburg · DEÉcole Normale Supérieure de Lyon · FR

Funding

Development of Aquatic Model Resources for Therapeutic ScreensR24OD018555 · OD · UNIVERSITY OF OREGON · PI POSTLETHWAIT, JOHN H. · 2014 to 2017
$2.6M
NIH HHS R24 OD018555NIH HHS R24OD018555
6 · The paper itself

Abstract

Melanoma development in interspecific hybrids of Xiphophorus is induced by the overexpression of the mutationally activated receptor tyrosine kinase Xmrk in pigment cells. Based on the melanocyte specificity of the transcriptional upregulation, a pigment cell-specific promoter region was postulated for xmrk, the activity of which is controlled in healthy purebred fish by the molecularly still unidentified regulator locus R. However, as yet the xmrk promoter region is still poorly characterized. In order to contribute to a better understanding of xmrk expression regulation, we performed a functional analysis of the entire putative gene regulatory region of the oncogene using conventional plasmid-based reporter systems as well as a newly established method employing BAC-derived luciferase reporter constructs in melanoma and non-melanoma cell lines. Using the melanocyte-specific mitfa promoter as control, we could demonstrate that our in vitro system is able to reliably monitor regulation of transcription through cell type-specific regulatory sequences. We found that sequences within 200kb flanking the xmrk oncogene do not lead to any specific transcriptional activation in melanoma compared to control cells. Hence, xmrk reporter constructs fail to faithfully reproduce the endogenous transcriptional regulation of the oncogene. Our data therefore strongly indicate that the melanocyte-specific transcription of xmrk is not the consequence of pigment cell-specific cis-regulatory elements in the promoter region. This hints at additional regulatory mechanisms involved in transcriptional control of the oncogene, thereby suggesting a key role for epigenetic mechanisms in oncogenic xmrk overexpression and thereby in tumor development in Xiphophorus.

Indexed as

AnimalsCell LineCyprinodontiformesFish ProteinsGene Expression Regulation, NeoplasticMelanomaMutationOncogenesPromoter Regions, GeneticReceptor Protein-Tyrosine KinasesSignal TransductionTranscriptional ActivationTranscription, GeneticFish ProteinsReceptor Protein-Tyrosine KinasesXmrk protein, XiphophorusCis-regulatory elementEGF receptorMelanomaPigment cellTranscriptional controlTumor suppressorXiphophorusxmrk oncogene

Identifiers

PMID26348392
PMCPMC4662873
OpenAlexW1557165169

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.